Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global approaches to infectious disease surveillance and modeling.

Nature medicine·2026
Same author

The rise and fall of HIV in Kinshasa over a century.

AIDS (London, England)·2026
Same author

The emergence and molecular evolution of H5N1 influenza viruses in United States dairy cattle.

bioRxiv : the preprint server for biology·2026
Same author

Transmission lineage dynamics and the detection of viral importation in emerging epidemics.

Epidemics·2026
Same author

SERAPHIM 2.0: an extended toolbox for studying phylogenetically informed movements.

Bioinformatics (Oxford, England)·2026
Same author

Genomic characterization of Sabiá virus in Brazil, 2019-2020: Implications for diagnostics, virus evolution, and receptor binding.

PLoS neglected tropical diseases·2026

Related Experiment Video

Updated: May 23, 2026

Field Postmortem Rabies Rapid Immunochromatographic Diagnostic Test for Resource-Limited Settings with Further Molecular Applications
07:40

Field Postmortem Rabies Rapid Immunochromatographic Diagnostic Test for Resource-Limited Settings with Further Molecular Applications

Published on: June 29, 2020

Human parvovirus 4 infection, Cameroon.

Myriam Lavoie1, Colin P Sharp, Jacques Pépin

  • 1Université de Sherbrooke, Sherbrooke, Quebec, Canada.

Emerging Infectious Diseases
|April 4, 2012
PubMed
Summary

Parvovirus 4 (PARV4) seroprevalence was studied in elderly Cameroonians. Findings suggest parenteral routes, like certain medical treatments, may contribute to PARV4 infection acquisition.

More Related Videos

Preparation of Pseudo-Typed H5 Avian Influenza Viruses with Calcium Phosphate Transfection Method and Measurement of Antibody Neutralizing Activity
07:15

Preparation of Pseudo-Typed H5 Avian Influenza Viruses with Calcium Phosphate Transfection Method and Measurement of Antibody Neutralizing Activity

Published on: November 22, 2021

The α-test: Rapid Cell-free CD4 Enumeration Using Whole Saliva
11:22

The α-test: Rapid Cell-free CD4 Enumeration Using Whole Saliva

Published on: May 16, 2012

Related Experiment Videos

Last Updated: May 23, 2026

Field Postmortem Rabies Rapid Immunochromatographic Diagnostic Test for Resource-Limited Settings with Further Molecular Applications
07:40

Field Postmortem Rabies Rapid Immunochromatographic Diagnostic Test for Resource-Limited Settings with Further Molecular Applications

Published on: June 29, 2020

Preparation of Pseudo-Typed H5 Avian Influenza Viruses with Calcium Phosphate Transfection Method and Measurement of Antibody Neutralizing Activity
07:15

Preparation of Pseudo-Typed H5 Avian Influenza Viruses with Calcium Phosphate Transfection Method and Measurement of Antibody Neutralizing Activity

Published on: November 22, 2021

The α-test: Rapid Cell-free CD4 Enumeration Using Whole Saliva
11:22

The α-test: Rapid Cell-free CD4 Enumeration Using Whole Saliva

Published on: May 16, 2012

Area of Science:

  • * Virology and epidemiology of emerging human viruses.
  • * Public health and infectious disease research in Sub-Saharan Africa.

Background:

  • * Parvovirus 4 (PARV4) is a recently identified human parvovirus with unknown transmission routes.
  • * Understanding PARV4 epidemiology is crucial for public health, especially in resource-limited settings.

Purpose of the Study:

  • * To determine the seroprevalence of parvovirus 4 (PARV4) in an elderly population in Cameroon.
  • * To investigate potential risk factors and transmission pathways for PARV4 infection.

Main Methods:

  • * Post hoc analysis of serum samples collected in 2009 from elderly Cameroonians.
  • * Serological testing for PARV4 antibodies.
  • * Statistical analysis to identify associations with clinical data and prior treatments.

Main Results:

  • * PARV4 seropositivity was detected in the studied population.
  • * Significant associations were found between PARV4 seropositivity and receipt of intravenous antimalarial drugs, intramuscular streptomycin, and intramuscular contraceptives.
  • * No association was observed between PARV4 seropositivity and hepatitis C virus seropositivity.

Conclusions:

  • * The findings suggest that parenteral exposure, particularly through medical interventions, may be a significant route for PARV4 acquisition.
  • * Further research is warranted to elucidate the specific mechanisms of parenteral transmission and the clinical significance of PARV4 infections.